![]() |
½ÃÀ庸°í¼
»óÇ°ÄÚµå
1501635
À¯·´ÀÇ °íÈ°¼º API ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø(2023-2033³â)Europe Highly Potent API Market - Analysis and Forecast, 2023-2033 |
À¯·´ÀÇ °íÈ°¼º API ½ÃÀå ±Ô¸ð´Â 2023³â 59¾ï 8,000¸¸ ´Þ·¯¿¡¼ ¿¹Ãø ±â°£ µ¿¾È CAGR 10.57%·Î ÃßÀÌÇÏ°í, 2033³â¿¡´Â 163¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
°íÈ°¼º API ½ÃÀåÀÇ È®´ë¸¦ µÞ¹ÞħÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¾Ï ÀÌȯÀ² Áõ°¡¿Í APIÀÇ Ä¡·á ¿ëµµÀÇ È®»êÀÔ´Ï´Ù.
ÁÖ¿ä ½ÃÀå Åë°è | |
---|---|
¿¹Ãø ±â°£ | 2023-2033³â |
2023³â Æò°¡ | 59¾ï 8,000¸¸ ´Þ·¯ |
2033³â ¿¹Ãø | 163¾ï 3,000¸¸ ´Þ·¯ |
CAGR | 10.57% |
À¯·´ÀÇ °íÈ°¼º API ½ÃÀåÀº ¾Ï ÀÌȯÀ²ÀÌ Áõ°¡ÇÏ°í ´Ù¾çÇÑ Ä¡·á ¿µ¿ª¿¡¼ HPAPIÀÇ ÀÀ¿ëÀÌ È®´ëµÊ¿¡ µû¶ó ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ °ß°íÇÑ Á¦¾à »ê¾÷Àº ÷´Ü R&D ½Ã¼³°ú ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿¡ ÈûÀÔ¾î ½ÃÀå °³¹ßÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. À¯·´ÀÇ ÁÖ¿ä ±â¾÷Àº ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Á¦Á¶ ´É·Â°ú °øµ¿ Á¦ÈÞ¿¡ ¸¹Àº ÅõÀÚ¸¦ ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Çõ½ÅÀûÀÎ ±â¼ú°ú °øÁ¤À» äÅÃÇÏ¿© °íÇ°ÁúÀÇ ¾ÈÀüÇÑ HPAPI »ý»êÀ» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ °íÈ°¼º ÈÇÕ¹°ÀÇ Ãë±Þ¿¡ Àͼ÷ÇÏ°í ¾ÈÀü¼º°ú ȯ°æ ±ÔÁ¦ Áؼö¸¦ È®º¸ÇÏ°í Á¦¾à ±â¾÷ÀÇ ¿î¿µ ºñ¿ëÀ» Àý°¨ÇÏ´Â Àü¹®ÀûÀÎ Á¦Á¶ À§Å¹ ±â°ü(CMO)¿¡ ´ëÇÑ ¾Æ¿ô¼Ò½Ì °æÇâÀÌ °ÇØÁö°í ÀÖÀ½ ½ÃÀåÀ» ¹Ð¾îÁÖ°í ÀÖ½À´Ï´Ù.
º» º¸°í¼¿¡¼´Â À¯·´ÀÇ °íÈ°¼º API ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ¾÷°è µ¿Çâ, ±â¼ú¡¤Æ¯Çã µ¿Çâ, ¹ý±ÔÁ¦ ȯ°æ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.
Introduction to Europe Highly Potent API Market
The Europe highly potent API market is projected to reach $16.33 billion by 2033 from $5.98 billion in 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033. The primary factors propelling the expansion of the highly potent API market are the rising incidence of cancer, which boosts the demand for highly potent APIs, and the broadening range of therapeutic applications for these APIs.
KEY MARKET STATISTICS | |
---|---|
Forecast Period | 2023 - 2033 |
2023 Evaluation | $5.98 Billion |
2033 Forecast | $16.33 Billion |
CAGR | 10.57% |
Market Introduction
The Europe Highly Potent API market is experiencing significant growth, driven by increasing cancer prevalence and the expanding application of HPAPIs in various therapeutic areas. The region's robust pharmaceutical industry, supported by advanced R&D facilities and stringent regulatory frameworks, enhances market development. Key players in Europe are investing heavily in manufacturing capabilities and collaborative partnerships to meet the rising demand. Additionally, the adoption of innovative technologies and processes ensures the production of high-quality, safe HPAPIs. The market is further fueled by the growing outsourcing trend to specialized contract manufacturing organizations (CMOs) with expertise in handling highly potent compounds, ensuring compliance with safety and environmental regulations, and reducing operational costs for pharmaceutical companies.
Market Segmentation:
Segmentation 1: by Country
How can this report add value to an organization?
Competitive Strategy: The highly potent API market has numerous established players with product and service portfolios. Key players in the Europe highly potent API market analysed and profiled in the study involve established players offering products and services of highly potent API.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, type portfolio, and market penetration.
Some prominent names in the market include:
Scope and Definition